Mechanisms of enhanced lung injury during sepsis

American Journal of Pathology

Volumn 154, Issue 4, 1999, Pages 1057-1065

  Czermak, Boris J ^a,b   Breckwoldt, Maren ^a   Ravage, Zachary B ^b   Huber Lang, Markus ^b   Schmal, Hagen ^a   Bless, Nicolas M ^a   Friedl, Hans P ^a   Ward, Peter A ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHEMOKINE; COMPLEMENT COMPONENT C5A; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOKINESIS; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNE COMPLEX DEPOSITION; INFECTION SENSITIVITY; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG INJURY; LUNG LAVAGE; MACROPHAGE ACTIVATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0032943578     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65358-8     Document Type: Article

References (34)

1. Young LS: Gram-negative sepsis. Principles and Practice of Infectious Diseases. Edited by GL Mandell, SD Douglas, and JC Bennett. New York, John Wiley and Sons, 1979, pp 571-608
2. Bone RC: The sepsis syndrome: definition and general approach to management. Clin Chest Med 1996, 17:175-181
3. Kaplan RL, Sahn SA, Petty TL: Incidence and outcome of respiratory distress syndrome in gram-negative sepsis. Arch Intern Med 1979, 139:867-869
4. Moore FA, Moore EE, Read RA: Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horizons 1993, 1:538-549
5. Polk HC, Shields CL: Remote organ failure: a valid sign of occult intra-abdominal infection. Surgery 1977, 81:310-331
6. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655
7. Border JR, Hasett J, LaDuca J, Seibel R, Steinberg S, Mills B, Losi P, Border D: The gut origin sepsis state in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg 1987, 206:427-448
8. Wichtermann KA, Bauer AE, Chaudry IH: Sepsis and shock: a review of laboratory models and a proposal. J Surg Res 1980, 29:189-201
9. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL: Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 1996, 64:4733-4738
10. Ertel W, Morrison MH, Wang P, Zheng F, Ayala A, Chaudry IH: The complex pattern of cytokines in sepsis. Ann Surg 1991, 214:141-148
11. Moore FA, Moore EE: Evolving concepts in the pathogenesis of multiple organ failure. Surg Clin North Am 1995, 75:257-277
12. Johnson KJ, Ward PA: Acute immunologic pulmonary alveolitis. J Clin Invest 1974, 54:349-357
13. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA: Role for MIP-2 in LPS-induced lung injury in rats. J Immunol 1996, 156:1963-1972
14. Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP, Ward PA: Requirement for the C-X-C chemokines: MIP-2 and CINC in IgG immune complex-induced lung injury. J Immunol 1997, 158:3439-3448
15. Mulligan MS, Schmid E, Beck-Schimmer B, Till GO, Friedl HP, Brauer RB, Hugli TE, Miyasaka M, Warner RL, Johnson KJ, Ward PA: Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest 1996, 98:503-512
16. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA: Tumor necrosis factor-α regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 1993, 142:1739-1749
17. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor, tumor necrosis factor from human monocytes. J Immunol Methods 1986, 95:99-105
18. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators interleukins-1 and -6 and tumor necrosis factor. Circ Shock 1992, 36:191-199
19. McMasters KM, Cheadle WG: Regulation of macrophage TNF-α, IL-1β, and Ia (I-Aα) mRNA expression during peritonitis is site dependent. J Surg Res 1993, 54:426-430
20. Mulligan MS, Schmid E, Till GO, Hugli TE, Friedl HP, Roth RA, Ward PA: C5a-dependent up-regulation in vivo of lung vascular P-selectin. J Immunol 1997, 158:1857-1861
21. Nakae H, Endo S, Inada K, Yoshida M: Chronological changes in the complement system in sepsis. Jpn J Surg. 1996, 26:225-229
22. Quezado ZM, Hoffman WD, Winkelstein JA, Yatsiv I, Koev CA Cork LC, Elin RJ, Eichacker PQ, Natanson C: The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. J Exp Med 1994, 179:569-578
23. May JE, Kane MA, Frank MM: Host defense against bacterial endotoxemia: contribution of the early and late components of complement to detoxification. J Immunol 1972, 109:893-895
24. Johnson KJ, Ward PA: Protective function of C6 in rabbits treated with bacterial endotoxin. J Immunol 1971, 106:1125-1127
25. Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR, Warren HB, Lage AL, Moore FD, Rosen FS, Carroll MC: Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol 1997, 159:976-982
26. Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC: Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA 1995, 92:11490-11494
27. Barton PA, Warren JS: Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect Immun 1993, 61:1474-1481
28. Smedegård G, Cui L, Hugli TE: Endotoxin-induced shock in the rat: a role for C5a. Am J Pathol 1989, 135:489-497
29. Stevens JH, O'Hanley P, Shapiro JM, Mihm FG, Satoh PS, Collins JA, Raffin TA: Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest 1986, 77:1812-1816
30. Mohr M, Höpken U, Oppermann M, Mathes C, Goldmann K, Siever S, Götze O, Burchardi H: Effects of anti-C5a monoclonal antibodies on oxygen use in a porcine model of severe sepsis. Eur J Clin Invest 1998, 28:227-234
31. Olsen LM, Moss GS, Baukus O, Das Gupta TP: The role of C5a in septic lung injury. Ann Surg 1985, 202:771-776
32. Höpken UE, Mohr M, Strüber A, Montz H, Burchardi H, Götze O, Oppermann M: Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies. Eur J Immunol 1996, 26:1103-1109
33. Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS: Enhancement by the complement membrane attack complex of tumor necrosis factor-α induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995, 155:1434-1441
34. Bassal S, Liu YS, Thomas RJ, Philips WA: Phosphotyrosine activity in the macrophage is enhanced by lipopolysaccharide, tumor necrosis factor α, and granulocyte/macrophage-colony stimulating factor: correlation with priming of the respiratory burst. Biochim. Bioophys. Acta 1997, 1355:343-352